Results 131 to 140 of about 19,748 (246)

Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab

Pharmacogenomics and Personalized Medicine, 2014
Lukáš Smolej 4th Department of Internal Medicine – Hematology, University Hospital Hradec Králové and Charles University in Prague, Faculty of Medicine in Hradec Králové, Hradec Králové, Czech
Smolej L
doaj  

Molecular Chlorambucil-Methionine Conjugate: Novel Anti-cancer Agent against Breast MCF-7 Cell Model

, 2013
Farnoor Davachi Omoomi
openalex   +1 more source

Ovarian T-cell lymphoma in a dog with chronic protein-losing enteropathy. [PDF]

Acta Vet Scand
Mortensen JK, Wikström E, van de Velde N.   +2 more
europepmc   +1 more source

Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia [PDF]

, 2013
Stefan Walzer, C. Tournier, John-Paul Marino, Erik T. Mueller, M. Duong   +4 more
openalex   +1 more source

Primary portal vein hypoplasia in cats: clinical findings, diagnosis and outcomes in five cases. [PDF]

J Feline Med Surg
Bent N, Kearns S, Mouser P, Ewing P.
europepmc   +1 more source

A comparative health economic evaluation of venetoclax in combination with obinutuzumab versus Chlorambucil in combination with obinutuzumab as first-line treatment for chronic lymphocytic leukemia in China: a cost-effectiveness analysis. [PDF]

Cost Eff Resour Alloc
Du J, Ran H, Zheng Z, Yu X, Feng T.
europepmc   +1 more source

Research Progress on Zanubrutinib and Chlorambucil for CLL Therapy [PDF]

Shujun Fan
openalex   +1 more source

Sézary syndrome presenting as vitiligo-like leukoderma with response and repigmentation to mogamulizumab and extracorporeal photopheresis. [PDF]

JAAD Case Rep
Anderson E, Puccio J, Mou E, Swick B, Liu V.   +4 more
europepmc   +1 more source

Clinical practice guidelines for the diagnosis and management of chronic lymphocytic leukemia in Saudi Arabia: consensus statement by an expert panel. [PDF]

Front Med (Lausanne)
Alotaibi G, Aleem A, Absi A, Alaskar AS, Alfraih F, Alhejazi A, Almasari A, Alzahrani MF, Motabi I, El Fakih R.   +9 more
europepmc   +1 more source

Efficacy and safety of the obinutuzumab-chlorambucil combination in the frontline treatment of elderly CLL patients with comorbidities – Polish Adult Leukemia Group (PALG) real-life analysis [PDF]

, 2018
Monika Długosz‐Danecka, Wojciech Jurczak, Ewa Łątka-Cabała, Marta Morawska, Krzysztof Gawroński, Anna Wiśniewska, Marek Dudziński, Ewa Wąsik‐Szczepanek, Ewa Chmielowska, Anna Łabędź‐Masłowska, Kamil Wdowiak, Iwona Hus   +11 more
openalex   +1 more source